ICU Medical, Inc. (ICUI) Shares Sold by Teachers Retirement System of The State of Kentucky
Teachers Retirement System of The State of Kentucky trimmed its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 2.2% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 12,697 shares of the medical instruments supplier’s stock after selling 288 shares during the period. Teachers Retirement System of The State of Kentucky owned 0.06% of ICU Medical worth $2,190,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in the business. Personal Capital Advisors Corp acquired a new stake in ICU Medical during the 2nd quarter valued at $1,494,000. Royce & Associates LP boosted its position in shares of ICU Medical by 26.7% in the second quarter. Royce & Associates LP now owns 47,400 shares of the medical instruments supplier’s stock worth $8,177,000 after buying an additional 10,000 shares during the period. Schwab Charles Investment Management Inc. boosted its position in shares of ICU Medical by 8.4% in the first quarter. Schwab Charles Investment Management Inc. now owns 62,048 shares of the medical instruments supplier’s stock worth $9,475,000 after buying an additional 4,829 shares during the period. Fiera Capital Corp acquired a new stake in shares of ICU Medical in the second quarter worth $36,962,000. Finally, KBC Group NV boosted its position in shares of ICU Medical by 66.0% in the first quarter. KBC Group NV now owns 4,338 shares of the medical instruments supplier’s stock worth $662,000 after buying an additional 1,724 shares during the period. 78.13% of the stock is currently owned by institutional investors.
A number of research analysts have recently weighed in on ICUI shares. BidaskClub downgraded ICU Medical from a “buy” rating to a “hold” rating in a report on Tuesday, July 11th. Sidoti lowered ICU Medical from a “buy” rating to a “neutral” rating in a research report on Tuesday, June 20th. Zacks Investment Research raised ICU Medical from a “hold” rating to a “buy” rating and set a $193.00 price objective for the company in a research note on Thursday, July 20th. Finally, Gabelli reissued a “buy” rating on shares of ICU Medical in a research note on Friday, August 11th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $193.00.
ICU Medical, Inc. (NASDAQ:ICUI) opened at 188.00 on Tuesday. ICU Medical, Inc. has a 1-year low of $125.04 and a 1-year high of $188.85. The firm has a market cap of $3.73 billion, a price-to-earnings ratio of 75.29 and a beta of 0.35. The firm has a 50-day moving average of $176.76 and a 200 day moving average of $166.56.
ICU Medical (NASDAQ:ICUI) last released its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.06). ICU Medical had a net margin of 6.10% and a return on equity of 7.56%. The business had revenue of $331.51 million during the quarter, compared to the consensus estimate of $318.30 million. During the same period last year, the business posted $1.15 EPS. The firm’s revenue for the quarter was up 242.8% on a year-over-year basis. Analysts expect that ICU Medical, Inc. will post $4.11 earnings per share for the current fiscal year.
In related news, CFO Scott E. Lamb sold 23,772 shares of the company’s stock in a transaction dated Tuesday, July 11th. The stock was sold at an average price of $170.02, for a total transaction of $4,041,715.44. Following the sale, the chief financial officer now owns 9,050 shares in the company, valued at $1,538,681. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert S. Swinney sold 4,477 shares of the company’s stock in a transaction dated Thursday, July 20th. The stock was sold at an average price of $175.00, for a total value of $783,475.00. Following the sale, the director now owns 23,293 shares in the company, valued at approximately $4,076,275. The disclosure for this sale can be found here. Insiders have sold a total of 213,012 shares of company stock worth $36,438,659 over the last three months. Insiders own 15.90% of the company’s stock.
ICU Medical Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI).
Receive News & Stock Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related stocks with our FREE daily email newsletter.